Lauric Haber

Person

Rye Brook, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Multispecific antigen-binding molecules for cell targeting and uses...
- Patent number 12,077,603
- Issue date Sep 3, 2024
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multispecific antigen-binding molecules for cell targeting and uses...
- Patent number 12,065,508
- Issue date Aug 20, 2024
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multispecific antigen-binding molecules for cell targeting and uses...
- Patent number 11,952,430
- Issue date Apr 9, 2024
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EGFR × CD28 multispecific antibodies
- Patent number 11,912,767
- Issue date Feb 27, 2024
- REGENERON PHARMACEUTICALS, INC.
- Dimitris Skokos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific an...
- Patent number 11,633,501
- Issue date Apr 25, 2023
- REGENERON PHARMACEUTICALS, INC.
- John Rudge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof
- Patent number 11,548,947
- Issue date Jan 10, 2023
- REGENERON PHARMACEUTICALS, INC.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific ant...
- Patent number 11,485,793
- Issue date Nov 1, 2022
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Grant
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof
- Patent number 11,453,721
- Issue date Sep 27, 2022
- Regeneran Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...
- Patent number 11,155,633
- Issue date Oct 26, 2021
- Regeneran Pharmaceuticals, Inc.
- Jessica R. Kirshner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-MUC16 antibodies
- Patent number 10,941,208
- Issue date Mar 9, 2021
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Grant
Anti-STEAP2 antibody drug conjugates, and compositions and uses the...
- Patent number 10,772,972
- Issue date Sep 15, 2020
- REGENERON PHARMACEUTICALS, INC.
- John Rudge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antigen-binding molecules that bind MUC16 and CD3, and c...
- Patent number 10,738,130
- Issue date Aug 11, 2020
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Grant
Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...
- Patent number 10,179,819
- Issue date Jan 15, 2019
- REGENERON PHARMACEUTICALS, INC.
- Jessica R. Kirshner
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
MULTISPECIFIC ANTIGEN-BINDING MOLECULES FOR CELL TARGETING AND USES...
- Publication number 20240368312
- Publication date Nov 7, 2024
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EGFR x CD28 MULTISPECIFIC ANTIBODIES
- Publication number 20230322927
- Publication date Oct 12, 2023
- Regeneron Pharmaceuticals, Inc.
- Dimitris Skokos
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230303696
- Publication date Sep 28, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230279113
- Publication date Sep 7, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230272078
- Publication date Aug 31, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20230272111
- Publication date Aug 31, 2023
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Multispecific Antigen-Binding Molecules for Cell Targeting and Uses...
- Publication number 20230068129
- Publication date Mar 2, 2023
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Multispecific Antigen-Binding Molecules for Cell Targeting and Uses...
- Publication number 20220251244
- Publication date Aug 11, 2022
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules That Bin...
- Publication number 20210403595
- Publication date Dec 30, 2021
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Optimized Anti-CD3 Bispecific Antibodies and Uses Thereof
- Publication number 20210253701
- Publication date Aug 19, 2021
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Multispecific Antigen-Binding Molecules for Cell Targeting and Uses...
- Publication number 20210047438
- Publication date Feb 18, 2021
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...
- Publication number 20200376136
- Publication date Dec 3, 2020
- Regeneron Pharmaceuticals, Inc.
- John Rudge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20200317810
- Publication date Oct 8, 2020
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR x CD28 MULTISPECIFIC ANTIBODIES
- Publication number 20200299388
- Publication date Sep 24, 2020
- Regeneron Pharmaceuticals, Inc.
- Dimitris Skokos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-MUC16 X ANTI-CD28 ANTIBODIES AND USES THEREOF
- Publication number 20200199233
- Publication date Jun 25, 2020
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-PSMA X ANTI-CD28 ANTIBODIES AND USES THEREOF
- Publication number 20190389951
- Publication date Dec 26, 2019
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Optimized Anti-CD3 Bispecific Antibodies and Uses Thereof
- Publication number 20180355038
- Publication date Dec 13, 2018
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20180118848
- Publication date May 3, 2018
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20180112001
- Publication date Apr 26, 2018
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...
- Publication number 20180104357
- Publication date Apr 19, 2018
- Regeneron Pharmaceuticals, Inc.
- John Rudge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Lauric Haber

Person

Patents Grantslast 30 patents

Multispecific antigen-binding molecules for cell targeting and uses...

Multispecific antigen-binding molecules for cell targeting and uses...

Multispecific antigen-binding molecules for cell targeting and uses...

EGFR × CD28 multispecific antibodies

Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific an...

Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof

Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific ant...

Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof

Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...

Anti-MUC16 antibodies

Anti-STEAP2 antibody drug conjugates, and compositions and uses the...

Bispecific antigen-binding molecules that bind MUC16 and CD3, and c...

Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...

Patents Applicationslast 30 patents

MULTISPECIFIC ANTIGEN-BINDING MOLECULES FOR CELL TARGETING AND USES...

EGFR x CD28 MULTISPECIFIC ANTIBODIES

Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof

Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof

Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

Multispecific Antigen-Binding Molecules for Cell Targeting and Uses...

Multispecific Antigen-Binding Molecules for Cell Targeting and Uses...

Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules That Bin...

Optimized Anti-CD3 Bispecific Antibodies and Uses Thereof

Multispecific Antigen-Binding Molecules for Cell Targeting and Uses...

Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

EGFR x CD28 MULTISPECIFIC ANTIBODIES

BISPECIFIC ANTI-MUC16 X ANTI-CD28 ANTIBODIES AND USES THEREOF

BISPECIFIC ANTI-PSMA X ANTI-CD28 ANTIBODIES AND USES THEREOF

Optimized Anti-CD3 Bispecific Antibodies and Uses Thereof

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...